Drug effects on triiodothyronine uptake by rat anterior pituitary cells in vitro

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 2, 1996, Pages 151-157

  Lim, C F ^a,c   Loidl, N M ^a   Kennedy, J A ^b   Topliss, D J ^a   Stockigt, J R ^a  

^a MONASH UNIVERSITY   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Anterior pituitary; Drugs; T3 uptake

Indexed keywords

3',5' DIBROMO 4',6 DIHYDROXY 3 METHYLFLAVONE; ACETYLSALICYLIC ACID; ALBUMIN; ANTICONVULSIVE AGENT; BUMETANIDE; DIURETIC AGENT; ETACRYNIC ACID; FENCLOFENAC; FUROSEMIDE; LIOTHYRONINE; LOOP DIURETIC AGENT; MECLOFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PIRETANIDE; THYROTROPIN;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; HORMONE TRANSPORT; HYPOPHYSIS CELL; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROTROPIN RELEASE;

EID: 0029892161     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211437     Document Type: Article

References (36)

1. Abend SL, Fang SL, Alex S, Braverman LE, Leonard JL: Rapid alteration in circulating free thyroxine modulates type II 5′ deiodinase and basal thyrotropin secretion in the rats. J Clin Invest 88: 898-903, 1991.
2. Docter R, Krenning EP: Role of cellular transport systems in the regulation of thyroid hormone bioactivity. In Monte AG (ed.). The thyroid gland, pp. 233-254, Raven Press, New York, 1990.
3. Emerson CH, Lew R, Braverman LE, DeVito WJ: Serum thyrotropin concentrations are more highly correlated with serum triiodothyronine concentrations than with serum thyroxine concentrations in thyroid hormone-infused thyroidectomized rats. Endocrinology 124: 2415-2418, 1989.
4. Everts ME, Docter R, Moerings EPMC, van Koetsveld PM, Visser TJ, de Jong M, Krenning EP, Hennamann G: Uptake of thyroxine in cultured anterior pituitary cells of euthyroid rats. Endocrinology 134: 2490-2497, 1994a.
5. Everts ME, Docter R, van Buuren JCJ, van Koetsveld PM, Hofland LJ, de Jong M, Krenning EP, Hennemann G: Evidence for carrier-mediated uptake of triiodothyronine in cultured anterior pituitary cells of euthyroid rats. Endocrinology 132: 1278-1285, 1993.
6. Everts ME, Lim C-F, Moerings EPCM, Docter R, Visser TJ, de Jong M, Krenning EP, Hennemann G: Different effects of a furan fatty acid and indoxyl sulfate on thyroid hormone uptake in pituitary and liver. Am J Physiol 268: E974-E979, 1995.
7. Everts ME, Visser TJ, Moerings EPCM, Docter R, van Toor H, Tempelaars AMP, de Jong M, Krenning EP, Hennamann G: Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology 135: 2700-2707, 1994b.
8. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH: Replacement dose, metabolism and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 316: 764-770, 1987.
9. 125I]-triiodothyronine binding to nuclear receptors in rat pituitary tumor cells. Endocrinology 110: 1070-1072, 1982.
10. 3 cells. J Biol Chem 257: 3139-3144, 1982.
11. Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT: Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab 51: 387-393, 1980.
12. Köhrle J, Fang SL, Yang Y, Irmscher K, Hesch RD, Pino S, Alex S, Braverman LW: Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinology 125: 532-537, 1989.
13. Krenning EP, Docter R, Bernard HF, Visser TJ, Hennemann G: Characteristics of active transport of thyroid hormone into rat hepatocytes. Biochim Biophys Acta 676: 314-320, 1981.
14. Lakshmanan M, Goncalves E, Lessly G, Foti D, Robbins J: The transport of thyroxine into mouse neuroblastoma cells, NB41A3: the effect of L-system amino acids. Endocrinology 126: 3245-3250, 1990.
15. Larsen PR, Silva JE, Kaplan MM: Relationships between circulating and intracellular thyroid hormones: Physiological and clinical implications. Endocr Rev 2: 87-102, 1981.
16. 4, and decreases serum thyrotropin in the rat. Endocrinology 126: 2890-2895, 1990.
17. Lim C-F, Bai Y, Topliss DJ, Barlow JW, Stockigt JR: Drug and fatty acid effects on serum thyroid hormone binding. J Clin Endocrinol Metab 67: 682-688, 1988.
18. Lim C-F, Bernard BF, de Jong M, Docter R, Krenning EP, Hennemann G: A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. J Clin Endocrinol Metab 76: 318-324, 1993.
19. Lim C-F, Loidl NM, Kennedy JA, Topliss DJ, Stockigt JR: Effect of loop diuretics and nonsteroidal antiinflammatory drugs on thyrotropin release by rat anterior pituitary cells in vitro. Metabolism 44: 1008-1012, 1995.
20. McEvoy GK (ed.).: In American Hospital Formulary Service: Drug Information, pp. 1700-1713, American Society of Hospital Pharmacists, Bethesda, 1994.
21. Mendel CA, Cavalieri RR, Gavin LA, Pettersson T, Inoue M: Thyroxine transport and distribution in Nagase analbuminemic rats. J Clin Invest 83: 143-148, 1989.
22. Nicoloff JT, Spencer CA: Integration of thyroid hormones with hypothalamic factors on pituitary TSH secretion. Acta Med Austriaca 19(Suppl 1): 68-71, 1992.
23. Noy N, Donnelly TM, Zakim D: Physical-chemical model for the entry of water-insoluble compounds into cells. Studies of fatty acid uptake by the liver. Biochemistry 25: 2013-2021, 1986.
24. Obergon MJ, Pascual A, Mollol J, Morreale de Escobar G, Escobar de Rey F: Evidence against a major role of L-thyroxine at the pituitary level: studies in rats treated with iopanoic acid (telepaque). Endocrinology 106: 1827-1836, 1980.
25. Re RN, Kourides IA, Ridgeway EC, Weintraub BD, Maloof F: The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab 43: 338-346, 1976.
26. Reynolds JEF (ed.).: In Martindale: The Extra Pharmacopoeia, 30th ed, pp 811-826, Pharmaceutical Press, London, 1993.
27. Silva JE, Dick TE, Larsen PR: The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3′-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology 103: 1196-1207, 1978.
28. Sterling K, Brenner MA: Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. J Clin Invest 45: 153-163, 1966.
29. Stockigt JR, Lim C-F, Barlow JW, Topliss DJ: Drug-induced disturbances of in vitro thyroid testing: Effects of circulating competitors for protein binding. Exp Clin Endocrinol 102 (Suppl 2): 110-116, 1994.
30. Surks MI, Ordene, KW, Mann DN, Kumara-Siri MH: Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat. J Clin Endocrinol Metab 56: 940-945, 1983.
31. Taylor R, Hutton C, Weeke J, Clark F: Fenclofenac-secondary effects upon the pituitary thyroid axis. Clin Endocrinol (Oxf) 19: 683-692, 1983.
32. Topliss DJ, Kolliniatis E, Barlow JW, Lim Chen-Fee, Stockigt JR: Uptake of 3,5,3′-triiodothyronine by cultured rat hepatoma cells is inhibitable by nonbile acid cholephils, diphenylhydantoin, and nonsteroidal antiinflammatory drugs. Endocrinology 124: 980-986, 1989.
33. van Doorn J, van der Heide D, Roelfsema F: Sources and the quantity of 3,5,3′-triiodothyronine in several tissues of the rat. J Clin Invest 72: 1778-1792, 1983.
34. 1 pituitary cells. J Biol Chem 268: 20179-20184, 1993.
35. Zemel LR, Biezunski DR, Shapiro LE, Surks MI: 5,5′-Diphenylhydantoin decreases the entry of 3,5,3′-triiodo-L-thyronine but not L-thyroxine in cultured GH-producing cells. Acta Endocrinol 117: 392-398, 1988.
36. Zhou Y, Samson M, Osty J, Francon J, Blondeau J-P: Evidence for a close link between the thyroid hormone transport system, and the amino acid transport T in erythrocytes. J Biol Chem 265: 17000-17004, 1990.